Research

Dr. Kudva's research focuses on improving existing treatments and developing novel therapies for people with type 1 and type 2 diabetes.

Our team is especially interested in developing an effective artificial pancreas and automated insulin delivery (AID) system. However, our research spans a wide breadth of novel treatment and care for adults, people who are pregnant, and children with diabetes.

Current studies

Current research studies and trials in our lab include:

INHALE-3: A 17-Week Randomized Trial and a 13-Week Extension, Evaluating the Efficacy and Safety of Inhaled Insulin (Afrezza) Combined With Insulin Degludec (Tresiba) Versus Usual Care in Adults With Type 1 Diabetes

The purpose of this study is to find out how well Afrezza plus a once-a-day injection of a long-acting insulin called insulin degludec works to control glucose levels compared with a person's current insulin delivery method.

A Randomized Trial Evaluating the Efficacy and Safety of Control-IQ Technology in Adults With Type 2 Diabetes Using Basal-Bolus Insulin Therapy (2IQP)

The aim of this study is to learn if an automated insulin delivery system can safely control blood sugar in people with type 2 diabetes.

Effectiveness and Safety of Dexcom Continuous Glucose Monitoring Systems in Non-Critically Ill Patients in the Inpatient Setting

The purpose of this study is to see how well the Dexcom Continuous Glucose Monitoring System works and how safe it is during hospitalization when worn for up to 10 days.

Supervised Enhanced Loop Algorithm Integrated With MAYO-ASU Controller in Pregnant Patients With Type 1 Diabetes With Extension Phase at Home Use

The main goal of this research trial is to improve glucose control in pregnant people with preexisting type 1 diabetes.

Glycemic Variability Assessment in Complex Diabetes During Hospitalization

The purpose of this research is to assess the glycemic variability in people with complex diabetes during hospitalization.

Open, Single Arm, Prospective, Multicenter Study of an Investigational Extended Wear Insulin Infusion Set During Home Use in People With Type 1 Diabetes

The main objective of this study is to evaluate SteadiSet device function as evidenced by the absence of device failure due to uncontrolled hyperglycemia with or without ketosis.

Harnessing Non-Glucose Feedback Signals for Automatic Glucose Control in Type 1 Diabetes: Confronting Exercise-Safety and Stress-Aware Control

The goal of this research project is to further develop continuous glucose monitors to better measure and predict glucose levels when people exercise or undergo physical exertion.

Research collaborators

Our lab collaborates with other diabetes experts around the United States to help advance treatment options for people with diabetes.

Our current external diabetes research collaborators include:

  • Ayan Banerjee
  • School of Computing and Augmented Intelligence
  • Arizona State University
  • Tempe, Arizona
  • Carol Levy, M.D., CDE
  • Division of Endocrinology, Diabetes and Bone Disease
  • Mount Sinai Diabetes Center
  • Icahn School of Medicine at Mount Sinai
  • New York, New York
  • Sarit Polsky, M.D.
  • Barbara Davis Center for Diabetes, Adult Clinic School of Medicine
  • University of Colorado Anschutz Medical Campus
  • Aurora, Colorado
  • Marzia Cescon, Ph.D.
  • Department of Mechanical Engineering
  • University of Houston
  • Houston, Texas